What is NDC 68382-608?

68382-608 is the product NDC for gabapentin, Gabapentin 300 mg/1 tablet, listed with the FDA by Zydus Pharmaceuticals USA Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.

Zydus Pharmaceuticals USA Inc., NDC labeler code 68382. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for gabapentin?

561 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

gabapentin NDC 68382-608 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)68382-608Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68382-0608Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
68382-608-05	6838206080568382060805	500 TABLET in 1 BOTTLE (68382-608-05)Marketed from Jan 25, 2024
68382-608-16	6838206081668382060816	90 TABLET in 1 BOTTLE (68382-608-16)Marketed from Jan 25, 2024
68382-608-77	6838206087768382060877	10 BLISTER PACK in 1 CARTON (68382-608-77) / 10 TABLET in 1 BLISTER PACK (68382-608-30)Marketed from Jan 25, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): gabapentin
Generic name (nonproprietary): gabapentin
Active ingredients: Gabapentin — 300 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Zydus Pharmaceuticals USA Inc.NDC labeler code 68382
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203934
Marketing start: Jan 25, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 68382-608_898c1710-d86c-4fbe-9a53-34661fcdb63aSPL ID 898c1710-d86c-4fbe-9a53-34661fcdb63aSPL set ID 3cfd04ab-e421-441f-a10e-e4dd1412974dRxCUI 1806380, 1806382, 2634743, 2634747, 2634751UNII 6CW7F3G59XUPC 0368382607164

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468382060805 followed by a unit qualifier and the quantity

Package 68382-0608-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 5, 2025.

Indications (excerpt from the label)

Gabapentin tablet is indicated for the management of postherpetic neuralgia. Once-daily gabapentin tablets are not substitutable with other gabapentin products because of differing pharmacokinetic profiles that affect the frequency of administration. Gabapentin tablet is indicated for the management of Postherpetic Neuralgia (PHN). Important Limitation Once-daily gabapentin tablets are not substitutable with other gabapentin products because of differing pharmacokinetic profiles that affect the frequency of administration (see Warnings and Precautions).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68382-608

What is NDC 68382-608?: 68382-608 is the product NDC for gabapentin, Gabapentin 300 mg/1 tablet, listed with the FDA by Zydus Pharmaceuticals USA Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: gabapentin.
What is the active ingredient?: Gabapentin.
Who is the labeler?: Zydus Pharmaceuticals USA Inc., NDC labeler code 68382. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for gabapentin?: 561 other product NDCs are listed under this name. See all gabapentin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other gabapentin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Gabapentin	Gabapentin 800 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-943	60760-0943-3060760-0943-90
gabapentin	Gabapentin 300 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4763	70518-4763-00
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Cardinal Health 107, LLC	55154-0581	55154-0581-00
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Advanced Rx of Tennessee, LLC	80425-0595	80425-0595-0180425-0595-0280425-0595-03+1 more
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4746	70518-4746-0070518-4746-0170518-4746-02+1 more
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4742	70518-4742-0070518-4742-02
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4740	70518-4740-0070518-4740-01
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Cardinal Health 107, LLC	55154-0580	55154-0580-00
Gabapentin	Gabapentin 600 mg/1	Tablet, CoatedOral	Coupler LLC	67046-1233	67046-1233-03
Gabapentin	Gabapentin 200 mg/1	CapsuleOral	Trifluent Pharma, LLC	73352-231	73352-0231-01

All 562 gabapentin NDCs

Other NDCs under ANDA 203934

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203934
Product	Strength	Form · route	Labeler	Product NDC
gabapentin	Gabapentin 450 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	68382-355
gabapentin	Gabapentin 750 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	68382-356
gabapentin	Gabapentin 900 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	68382-357
gabapentin	Gabapentin 600 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	68382-607
gabapentin	Gabapentin 300 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1861
gabapentin	Gabapentin 600 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1862
gabapentin	Gabapentin 450 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1916
gabapentin	Gabapentin 750 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1917
gabapentin	Gabapentin 900 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1918